BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Brain Council (EBC)
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250702T143000
DTEND;TZID=UTC:20250702T163000
DTSTAMP:20260423T041600
CREATED:20250625T121350Z
LAST-MODIFIED:20250625T121928Z
UID:57887-1751466600-1751473800@www.braincouncil.eu
SUMMARY:Headway – A New Roadmap in Brain Health: Focus Epilepsy
DESCRIPTION:Join us for a high-level policy event co-hosted by MEP Romana Jerković (S&D\, Croatia) and MEP Tomislav Sokol (EPP\, Croatia): “Headway – A New Roadmap in Brain Health: Focus Epilepsy”. The event will take place on Wednesday\, 2 July 2025\, from 14:30 to 16:30 CEST at the European Parliament\, Room SPAAK 4B1\, in Brussels. \nAs Europe grapples with ongoing geopolitical instability and the lasting impact of recent health crises\, building long-term resilience requires more than just economic reform. It demands a renewed focus on brain health. Prioritising neurological well-being is not only key to improving individual quality of life but also essential for preserving Europe’s social cohesion\, economic innovation\, and global competitiveness. \nThis event will bring together policymakers\, clinicians\, researchers\, patient advocates and industry leaders to address epilepsy\, one of the most common yet under-recognised neurological conditions in Europe. Despite affecting millions\, up to 40% of epilepsy patients still lack access to adequate treatment. The discussion will emphasise the urgent need for inclusive\, data-driven policy and integrated care pathways\, while situating epilepsy within the broader brain health agenda. \nDuring the event\, the latest edition of the Headway report will be presented\, developed by Angelini Pharma in partnership with TEHA Group. Since its inception in 2017\, the Headway initiative has championed a cross-sectoral approach to brain health\, addressing systemic challenges across healthcare\, education\, and the workplace. \nThe agenda will spotlight expert perspectives on the implementation of the WHO Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders across Europe. It will bring together a diverse range of voices\, including international patient organizations\, leading clinicians\, and senior EU policymakers. Notable contributions will come from figures such as MEP Vytenis Andriukaitis (S&D\, Lithuania)\, MEP András Tivadar Kulja (EPP\, Hungary)\, and MEP Aurelijus Veryga (ECR\, Lithuania)\, who will share their insights on how to translate global frameworks into concrete action within European health systems. \nThe European Brain Council (EBC) looks forward to being part of the event. Frédéric Destrebecq\, EBC Executive Director will take part in a roundtable discussion “Making Brain Health (and Epilepsy) a Public Priority in the EU” where he will share his insights on how brain health can remain at the top of the EU policy agenda. \nThe session will conclude with remarks from Agnese Cattaneo\, Chief Medical Officer of Angelini Pharma\, and will be moderated by Jennifer Baker\, renowned EU affairs presenter and journalist. \nDiscover the programmeRegister now
URL:https://www.braincouncil.eu/event/headway-a-new-roadmap-in-brain-health-focus-epilepsy/
LOCATION:Brussels\, Belgium
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2025/06/Headway-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250708
DTEND;VALUE=DATE:20250713
DTSTAMP:20260423T041600
CREATED:20240227T143437Z
LAST-MODIFIED:20250702T112620Z
UID:53015-1751932800-1752364799@www.braincouncil.eu
SUMMARY:European Paediatric Neurology Society (EPNS) Congress 2025
DESCRIPTION:Building Our AlphabetThe 16th European Paediatric Neurology Society (EPNS) Congress will take place in Munich from 8 – 12 July 2025! \nPaediatric Neurology is a leading discipline. Combining the fascination for the child and the childs’ brain\, it is located in the center of medicine\, science and the understanding of human development. Paediatric Neurology is opening new horizons for acute and chronic health conditions. Leaps of innovation are taking place for methods\, medications\, interventions and brain research. Right now Paediatric Neurology transfers its’ visionary future to the children with neurological complexity. \nFor the 2025 EPNS Munich Congress the field is classified into A for Acute\, B for Brain\, Health & Science and C for Chronic. EPNS is building their own alphabet of research and care taking: dedicated to the children\, equipped for the extending variety of neuropaediatric diseases\, stimulating and integrating science. \nFrédéric Destrebecq\, EBC Executive Director\, will take part in an Early Morning Teaching Session on Wednesday 9th of July on ‘Advocacy Training for Child Neurology and Brain Health’. This session will be co-chaired with Prof. Dr. Anna Jansen\, Professor of Child Neurology at Vrije Universiteit Brussel (VUB) and the University of Antwerp (UA). The session will take place on 9 July 2025 at 07:30-08:15 in the room Saal 13b (ICM). \nAdditionally\, EBC will be present among the Society stands throughout the entirety of the congress! Whether you want to discuss our ongoing projects\, learn more about our mission\, or explore future events and collaboration opportunities – come find us!  \nHighlight TopicsFind Out More
URL:https://www.braincouncil.eu/event/epns-2025-congress/
LOCATION:ICM International Congress Center Munich\, Messegelände\, Munich\, 81823
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/02/EPNS2025_Banner_breit_1-1536x381-1.webp
END:VEVENT
END:VCALENDAR